2018 was a milestone year for Illumina China because we received NMPA approval of our diagnostic Next Generation Sequencing machine, MiSeqDx System – our first Illumina-branded…
In Conversation
We believe Puerto Rico needs to stand on its own feet to be able to grow again
Skyla is still a small company only operating in Taiwan, and it is our mission to work with larger partners who have innovative solutions but need…
Europe, in general, is a tough market, and among European countries, the UK and the Nordics are the most challenging in terms of HTA and market…
Our objective in Taiwan is to focus on networking and collaborations with both research institutes and universities across the nation.
Every year in Thailand we treat more than 466,000 patients with our general medicine portfolio
In terms of the healthcare market, China is actually very similar to Europe, where the healthcare budget management deeply depends on each province
In every program and research project NCKU engages in, be it basic biotechnology sequencing or a major robotics engineering project, the value of delivery has always…
With Mangoral, we are exclusively targeting patients with poor kidney functions that are not eligible for currently available products. That is an open space where there…
Today, I lead a diverse and talented team and manage Amaran under international standards to follow and fulfil our motto of “Work locally. Think and act…
In the life sciences industry, the key to our success lies in our strong focus on helping our customers achieve excellence in regulatory compliance
The development of medical research in NSYSU is quite different from other medical centres in Taiwan because we bring different areas of expertise to create cross-disciplinary…
